Back to results
US 5,529,902 AGranted
Direct fluorescence-conjugated immunoassay for platelet activation
AssigneeMayo Foundation for Medical Education and Research
InventorsBruce A. Kottke, Deyong Wen
Life of this patent
Estimating the term…
Abstract
A method is provided to measure the extent of platelet activation by fluorometrically determining the extent of expression of P-selectin in a platelet sample in vitro, using a maximally activated platelet sample as a reference standard.
Claims10
A fluorometric method for measuring platelet activation in a sample of platelets which is not exogenously activated comprising:
- (a) isolating in vitro a first sample of physiological material comprising platelets and a second sample of physiological material comprising platelets from a mammal, wherein said sample each contains a preselected number of platelets;
- (b) adding an amount of an activation agonist to said first sample in a liquid medium for a period of time effective to maximally activate the activatable platelets in said first sample;
- while maintaining the second sample in a liquid medium for an equivalent period of time;
- (c) forming binary labelled complexes with the activated platelets in each sample by adding to each sample an amount of
- (i) an anti-P-selectin antibody conjugated to a fluorescent label;
- or
- (ii) an anti-P-selectin antibody conjugated to a binding site for a detectable label followed by a detectable fluorescent label which specifically binds to said binding site;
- and
- (d) determining the fluorescence of the binary labelled complexes in each sample, wherein a ratio of the fluorescence of said second sample to said first sample provides a measure of the extent of platelet activation in said second sample.
6 more elements
Dependencies are inferred from the claim text.